PharmGen Science Inc Capital Reinvestment Ratio
PharmGen Science Inc capital reinvestment ratio. PharmGen Science Inc (004720) has a Capital Reinvestment Ratio of 0.42x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.91 Billion) in capital expenditures (₩799.96 Million). See PharmGen Science Inc (004720) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of PharmGen Science Inc (2011–2024)
Capital reinvestment ratio of PharmGen Science Inc from 2011 to 2024. This chart tracks PharmGen Science Inc's Capital Reinvestment Ratio across 10 annual periods. See 004720 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
PharmGen Science Inc Capital Reinvestment Ratio by Year (2011–2024)
PharmGen Science Inc capital reinvestment ratio by year from 2011 to 2024. For the full cash flow conversion analysis, see 004720 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | ₩2.38 Billion | ₩2.78 Billion | ▲ +92.9% |
| 2023 | 0.61x | ₩5.44 Billion | ₩3.29 Billion | ▼ -84.7% |
| 2021 | 3.95x | ₩7.78 Billion | ₩30.75 Billion | ▲ +143.6% |
| 2020 | 1.62x | ₩2.68 Billion | ₩4.34 Billion | ▼ -33.6% |
| 2019 | 2.44x | ₩2.52 Billion | ₩6.16 Billion | ▲ +1053.3% |
| 2018 | 0.21x | ₩4.22 Billion | ₩892.34 Million | ▼ -74.7% |
| 2017 | 0.84x | ₩1.84 Billion | ₩1.54 Billion | ▲ +88.9% |
| 2016 | 0.44x | ₩7.75 Billion | ₩3.43 Billion | ▲ +107.8% |
| 2015 | 0.21x | ₩3.62 Billion | ₩771.87 Million | ▼ -4.0% |
| 2011 | 0.22x | ₩2.89 Billion | ₩642.43 Million | — |